A Randomized, Multicenter, Phase III Trial of Tacrolimus/Methotrexate versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation
- Ages: 18 and older
- Sexes: All
- Accepts healthy volunteers?: No
For additional eligibility criteria, please contact the study team.
Contact the study team
Additional eligibility criteria and study procedure details can be explained by the study team. Please call or email:
KeywordsMyelodysplasia, Acute Leukemia, Chronic Myelogenous Leukemia (CML), Lymphoma
Principal InvestigatorMary Horowitz, MD, MS
Begin a new search for other research studies
Studies listed on this site have been approved by a UF Institutional Review Board (IRB), which works to ensure the welfare and rights of research participants as required by federal regulations. Study listings are provided by the UF Clinical and Translational Science Institute in collaboration with UF research teams and the UF IRBs.